Skip to content

Study · Not a test of the peptide alone · 2011

2 results

[Clinical effects of shen-nourishing and menstruation-regulating method combined with triptorelin acetate injection on patient with luteinized unruptured follicle syndrome].

Yan-hua C, Fang L, Shi N

Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine1 Dec 2011Cited by 1 (Europe PMC)

PMID22384543 (opens in a new tab)PepBankPUB-22384543

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  1. 01HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneRandomized controlled trialEfficacy outcome

    In LUFS patients, SNMRM plus triptorelin did not significantly increase ovulation rate compared with triptorelin alone.

    In plain wordsIn women with LUFS, SNMRM plus triptorelin did not significantly increase ovulation compared with triptorelin alone.

    Outcome
    No significant changeOvulation rate
    Study

    n = 62

    Comparator
    Triptorelin acetate injection alone
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Ovulation rate
    85.53%
    SNMRM plus triptorelin
    Ovulation rate
    79.07%
    triptorelin alone

    Source sentences

    Summary
    The ovulation rate in the treatment group was higher than that in the control group, but without significant difference (85.53% versus 79.07%, P > 0.05).
    3 context sentences
    Summary · context
    To study the clinical effects of Shen-nourishing and menstruation-regulating method (SNMRM) combined with Triptorelin Acetate Injection (TAI) on patients with luteinized unruptured follicle syndrome (LUFS).
    Summary · context
    Sixty-two LUFS patients were randomly assigned to the treatment group and the control group.
    Summary · context
    TAI was given to patients in the control group while SNMRM + TAI was given to those in the treatment group.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

  2. 02HumanNot a test of Triptorelin (Trelstar, Decapeptyl) aloneRandomized controlled trialEfficacy outcome

    In LUFS patients, SNMRM plus triptorelin increased pregnancy rate compared with triptorelin alone.

    In plain wordsIn women with LUFS, SNMRM plus triptorelin increased pregnancy rate compared with triptorelin alone.

    Outcome
    IncreasePregnancy rate
    Study

    n = 62

    Comparator
    Triptorelin acetate injection alone
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Pregnancy rate
    56.25%
    SNMRM plus triptorelin
    Pregnancy rate
    30%
    triptorelin alone

    Source sentences

    Summary
    The pregnancy rate was significantly higher in the treatment group than in the control group (56.25% vs 30.00%, P < 0.05).
    3 context sentences
    Summary · context
    To study the clinical effects of Shen-nourishing and menstruation-regulating method (SNMRM) combined with Triptorelin Acetate Injection (TAI) on patients with luteinized unruptured follicle syndrome (LUFS).
    Summary · context
    Sixty-two LUFS patients were randomly assigned to the treatment group and the control group.
    Summary · context
    TAI was given to patients in the control group while SNMRM + TAI was given to those in the treatment group.

    In this study, Triptorelin (Trelstar, Decapeptyl) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Triptorelin (Trelstar, Decapeptyl).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.